Investor insights
Sectors invested in
Funding rounds participated in
$112M sweet spot round size
Most of their 13 investments are in rounds between $60M and $135M
Investor type
Basic info
Industry
Date founded
2018
Investments made
Myeloid Therapeutics raised $73M on May 18, 2023
Investors: ARCH Venture Partners, 8VC and Newpath Partners
Orbital Therapeutics raised $270M on April 26, 2023
Investors: Heritage Medical Systems, ARCH Venture Partners, Redmile Group, Casdin Capital, LLC, Exor N.V., iGlobe Partners, The Invus Group and Newpath Partners
Chroma Medicine raised $135M on March 1, 2023
Investors: Osage University Partners (OUP), Sixth Street, T. Rowe Price, Omega Funds, Sofinnova Partners, Wellington Management, GV and Newpath Partners
Neumora raised $112M on October 11, 2022
Investors: Abu Dhabi Growth Fund (ADG), ARCH Venture Partners, Polaris Partners, Exor N.V., The Invus Group, F-Prime Capital Partners and Newpath Partners
Orbital Therapeutics raised undisclosed on September 7, 2022
Investors: ARCH Venture Partners, Andreessen Horowitz and Newpath Partners
Neumora raised $400M on October 7, 2021
Investors: re.Mind Capital, SoftBank Investment Advisers, Logos Global Management, LP, Surveyor Capital, F-Prime Capital Partners, The Invus Group, Polaris Partners and Newpath Partners
Exo Therapeutics raised $78M on October 5, 2021
Investors: 6 Dimensions Capital, Nextech Invest, Casdin Capital, LLC, Samsara BioCapital, CRV, Morningside Venture Capital 晨兴资本 and Newpath Partners
YourBio Health raised $21M on September 3, 2021
Investors: Flagship Ventures and Newpath Partners
Prime Medicine, Inc. raised $200M on July 13, 2021
Investors: Casdin Capital, LLC, GV, F-Prime Capital Partners, T. Rowe Price, Samsara BioCapital, Redmile Group and Newpath Partners
Kojin Therapeutics raised $60M on June 9, 2021
Investors: Leaps by Bayer, Eventide Asset Management, Cathay Capital, Polaris Partners and Newpath Partners